Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myeloid, Acute 5Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Recurrence 1Plasmacytoma 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Myeloid Malignancies 1Myelodysplastic Syndromes 1Multiple Myeloma 1Microsatellite Stable Colorectal Carcinoma 1Lung Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Hematologic Neoplasms 1Hematologic Diseases 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Rituximab 5Valganciclovir 3Zidovudine 2Methotrexate 2Leucovorin 2Doxorubicin 2merphos 1cc-486 1avelumab 1apatinib 1Vincristine 1Valacyclovir 1Vaccines 1Tomography, X-Ray Computed 1Prednisone 1Nivolumab 1Kidney Transplantation 1Interferons 1Hydroxyurea 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Etoposide 1Echocardiography 1EPOCH protocol 1Docetaxel 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Caves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Epstein-Barr Virus Infections × cc-486 × Clear all
NCT02269943 2018-12-12

Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Celgene

Phase 2 Completed
36 enrolled 24 charts
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡